Accelerated hippocampal atrophy rates in stable and progressive amnestic mild cognitive impairment

Studies suggest that smaller hippocampal volume predicts Alzheimer's disease (AD) in mild cognitive impairment (MCI). However, few studies have demonstrated decline rates in cognition and hippocampal volume in MCI subjects with stable clinical presentation. Furthermore, the effects of apolipoprotein E (ApoE) on the change rates of medial temporal structures and cognition in MCI are rarely investigated. Fifty-eight subjects with amnestic MCI and 20 normal aging elderly controls received annual neuropsychological and magnetic resonance imaging (MRI) assessments. Annual decline rates in neuropsychological test scores, hippocampal and amygdalar volumes were calculated. ApoE genotypes were examined. Nineteen (32.7%) MCI subjects converted to AD during an average 22.5-month follow-up period. The annual hippocampal atrophy rate was correlated with a decline in memory test scores. The presence of the ApoE varepsilon4 allele did not affect the change rates in neuropsychological test scores and medial temporal structures volume. Compared to subjects with stable MCI (MCI-S) and normal aging, progressive MCI (MCI-P) had the highest annual decline rates in cognition and hippocampal volume. Logistic regression analysis showed that higher annual decline rates in hippocampal volume and global cognitive test scores were associated with conversion to AD. Furthermore, although MCI-S subjects had little cognitive decline, their hippocampal atrophy rates were higher than those of normal aging controls. Therefore, accelerated hippocampal atrophy rates may be an early and important presentation in MCI subjects.

[1]  Eini Niskanen,et al.  Voxel-based morphometry to detect brain atrophy in progressive mild cognitive impairment , 2007, NeuroImage.

[2]  C. Jack,et al.  Longitudinal MRI findings from the vitamin E and donepezil treatment study for MCI , 2008, Neurobiology of Aging.

[3]  N. Raz,et al.  Shrinkage of the Entorhinal Cortex over Five Years Predicts Memory Performance in Healthy Adults , 2004, The Journal of Neuroscience.

[4]  Vesna Jelic,et al.  A critical discussion of the role of neuroimaging in mild cognitive impairment * , 2003, Acta neurologica Scandinavica. Supplementum.

[5]  D A Bennett,et al.  Hemispheric differences in hippocampal volume predict verbal and spatial memory performance in patients with Alzheimer's disease , 2000, Hippocampus.

[6]  Henry Rusinek,et al.  Regional brain atrophy rate predicts future cognitive decline: 6-year longitudinal MR imaging study of normal aging. , 2003, Radiology.

[7]  A Hofman,et al.  Hippocampal, amygdalar, and global brain atrophy in different apolipoprotein E genotypes , 2002, Neurology.

[8]  H. Soininen,et al.  Hippocampus and entorhinal cortex in mild cognitive impairment and early AD , 2004, Neurobiology of Aging.

[9]  S Lehéricy,et al.  Amygdalohippocampal MR volume measurements in the early stages of Alzheimer disease. , 1994, AJNR. American journal of neuroradiology.

[10]  W. M. van der Flier,et al.  Hippocampal atrophy in Alzheimer disease: Age matters , 2006, Neurology.

[11]  F. Lalonde,et al.  Effect of apolipoprotein E genotype on hippocampal volume loss in aging healthy women , 2001, Neurology.

[12]  P. Laursen.  The impact of aging on cognitive functions. An 11 year follow-up study of four age cohorts. , 1997, Acta neurologica Scandinavica. Supplementum.

[13]  Charles DeCarli,et al.  APOE-ε4 is associated with less frontal and more medial temporal lobe atrophy in AD , 1999, Neurology.

[14]  N. Schuff,et al.  Higher atrophy rate of entorhinal cortex than hippocampus in AD , 2004, Neurology.

[15]  Yaakov Stern,et al.  Memory performance in healthy elderly without Alzheimer’s disease: effects of time and apolipoprotein-E , 2001, Neurobiology of Aging.

[16]  C. Jack,et al.  Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD , 2004, Neurology.

[17]  David A. Bennett,et al.  Apolipoprotein gene and its interaction with the environmentally driven risk factors: molecular, genetic and epidemiological studies of Alzheimer’s disease , 2004, Neurobiology of Aging.

[18]  E. Corder,et al.  Apolipoprotein E-∈4 gene dose , 1995, The Lancet.

[19]  C. Jack,et al.  Rates of hippocampal atrophy correlate with change in clinical status in aging and AD , 2000, Neurology.

[20]  H C Charles,et al.  Impact of APOE in mild cognitive impairment , 2004, Neurology.

[21]  Sara Rosenblum,et al.  Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment. , 2006, Archives of general psychiatry.

[22]  H. Wiśniewski,et al.  In Vivo Structural Studies of the Hippocampus in Normal Aging and in Incipient Alzheimer's Disease a , 1996, Annals of the New York Academy of Sciences.

[23]  R. Wallace,et al.  Age, medical conditions, and gender as interactive predictors of cognitive performance: the effects of selective survival. , 2000, The journals of gerontology. Series B, Psychological sciences and social sciences.

[24]  C. Jack,et al.  Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment , 1999, Neurology.

[25]  C. Hong,et al.  epsilon 4 Allele of apolipoprotein E increases risk of Alzheimer's disease in a Chinese population , 1996, Neurology.

[26]  J Philip Miller,et al.  Longitudinal course and neuropathologic outcomes in original vs revised MCI and in pre-MCI , 2006, Neurology.

[27]  N. Schuff,et al.  Age effects on atrophy rates of entorhinal cortex and hippocampus , 2006, Neurobiology of Aging.

[28]  S. Resnick,et al.  Longitudinal change in hippocampal volume as a function of apolipoprotein E genotype , 2000, Neurology.

[29]  N. Schuff,et al.  Longitudinal volumetric MRI change and rate of cognitive decline , 2005, Neurology.

[30]  E. Teng,et al.  The Cognitive Abilities Screening Instrument (CASI): A Practical Test for Cross-Cultural Epidemiological Studies of Dementia , 1994, International Psychogeriatrics.

[31]  G. V. Van Hoesen,et al.  Hippocampal formation: anatomy and the patterns of pathology in Alzheimer's disease. , 1990, Progress in brain research.

[32]  C. Coffey,et al.  Quantitative cerebral anatomy of the aging human brain , 1992, Neurology.

[33]  C. Jack,et al.  Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease , 1998, Neurology.

[34]  F. Schmitt,et al.  Brain structural alterations before mild cognitive impairment , 2007, Neurology.

[35]  M. Rice,et al.  Ethnicity and Cognitive Performance Among Older African Americans, Japanese Americans, and Caucasians: The Role of Education , 2001, Journal of the American Geriatrics Society.

[36]  D. A. Bennett,et al.  Natural history of mild cognitive impairment in older persons , 2002, Neurology.

[37]  C. P. Hughes,et al.  A New Clinical Scale for the Staging of Dementia , 1982, British Journal of Psychiatry.

[38]  B. Winblad,et al.  The course of cognitive impairment in preclinical Alzheimer disease: three- and 6-year follow-up of a population-based sample. , 2000, Archives of neurology.

[39]  J. Lirng,et al.  Prediction of Alzheimer's disease in mild cognitive impairment: A prospective study in Taiwan , 2006, Neurobiology of Aging.

[40]  C. Jack,et al.  Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD , 2000, Neurology.

[41]  E. Tangalos,et al.  Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .

[42]  G Ratcliff,et al.  Patterns of cognitive decline in presymptomatic Alzheimer disease: a prospective community study. , 2001, Archives of general psychiatry.

[43]  H. Soininen,et al.  MRI of the Hippocampus in Alzheimer’s Disease: Sensitivity, Specificity, and Analysis of the Incorrectly Classified Subjects , 1998, Neurobiology of Aging.

[44]  M. Aartsen,et al.  Gender Differences in Level and Change in Cognitive Functioning , 2003, Gerontology.

[45]  C. Jack,et al.  MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment , 2008, Neurology.